TessArae Blog
News and Events from TessArae, LLC
TessArae Awarded Contract by Massachusetts Department of Public Health
TessArae® was awarded a contract from the Massachusetts Department of Public Health for the purchase of DNA instrumentation, supplies, with support for validation, bioinformatics integration and training. TessArae is a private company that designs and delivers the most cost-effective, highly multiplexed, targeted DNA sequencing diagnostics available on the market today, providing solutions for two key [...]
Posted in News, Press Releases | No Comments
TessArae Partners with Israeli Testing Firm GGA to Design Cancer-Resequencing Chip
Expanding its activities in the genetic testing market, TessArae has partnered with an Israeli firm to design a resequencing microarray that can detect specific disease-causing mutations in 11 cancer genes. Kazerin-based Galil Genetic Analysis will next month launch the Affymetrix-made chip, according to officials from both companies. GGA CEO Yoram Plotsky told BioArray News this [...]
Posted in News, Press Releases | No Comments
Klaus Schafer Selected to the Board of Directors of the Virginia Biotechnology Association (VABIO)
Dr. Klaus Schafer, President and CEO of TessArae, has been selected to serve on the board of directors of the Virginia Biotechnology Association. The Virginia Biotechnology Association (VABIO), formed in 1992, is the premier statewide non-profit trade association representing the life sciences industry in the Commonwealth of Virginia. Nearly 200 member organizations have joined forces [...]
Posted in News, Press Releases, Uncategorized | No Comments
TessArae to Attend American Society for Human Genetics Meeting 2010
TessArae will be in attendance at the 60th Annual Meeting of the American Society of Human Genetics meeting in Washington, DC on November 2-6, 2010. If you would like to speak to us, please contact us at: http://www.tessarae.com/contact.html. The TessArae Resequencing Diagnostic Microarray technology will also be discussed in a poster by Galil Genetic Analysis [...]
Posted in Meetings, News | No Comments
Case Study Highlights TessArae Capabilities
TessArae Targeted Resequencing at GeneDx Provides More Comprehensive Analysis, Lower Cost, and Faster Results GeneDx is a premier genetic testing company that specializes in rare hereditary disorders. In 2008 the scientific team determined that they needed to update their testing method for Noonan Syndrome to enhance their competitive position in the market, and engaged in [...]
Posted in News | No Comments
Matthew Lorence to Chair Session at Next Generation Dx Summit
The H1N1 epidemic has illuminated the need for new rapid molecular tests. Opportunities for point-of-care have arisen around the need for faster turnaround time and more sophisticated assays that differentiate strain types of emerging agents and that generate reliable results. This promises to improve healthcare delivery and make patient management more efficient with accurate diagnosis. [...]
Posted in Uncategorized | No Comments
Dr. Agnieszka Lichanska to Present at BioConference Live 2010
Presentation Abstract: TessArae’s Resequencing Pathogen Microarray (RPM) simultaneously detects and identifies hundreds of strains of viral and bacterial pathogens. Unlike PCR and immunoassays that employ a surrogate marker for detection (e.g. fluorescent signal), RPM results are the nucleotide sequences of pathogen-specific signatures such as determinants of host-range, pathogenicity, virulence, and resistance to antiviral drugs, thus providing [...]
Posted in Meetings, News | No Comments
FDA Grants Emergency Use Authorization for TessArae(R) 2009 H1N1 Influenza A Virus Assay Based on the Affymetrix(R) GeneChip(R) Platform
FDA Authorizes Emergency Use of Assay for the Detection and Differentiation of the 2009 H1N1 Influenza A Virus SANTA CLARA, Calif. & POTOMAC FALLS, Va., Dec 21, 2009 (BUSINESS WIRE) — TessArae, LLC, a privately held company, and Affymetrix Inc., (NASDAQ:AFFX) today announced that the Food and Drug Administration (FDA) has granted Emergency Use Authorization [...]
Posted in News, Press Releases | No Comments
BioArray News: TessArae, GeneDx Develop Array-Based Tests for Noonan, Periodic Fever Syndromes
Looking to move into the genetic-disease testing market, TessArae this week announced a deal with GeneDx to develop and launch array-based tools for detecting the genetic mutations responsible for several diseases. Under the terms of the deal, Potomac Falls, Va.-based TessArae will provide Gaithersburg, Md.-based GeneDx with arrays and software to detect all known mutations [...]
Posted in News | 2 Comments
Press Release: TessArae Delivers Lower Cost Option to Genetic Testing Market
POTOMAC FALLS, Va., Nov. 9 /PRNewswire/ — TessArae® LLC, a global leader in resequencing microarray-based applications, announces the launch of new integrated product solutions for genetic testing of the mutations that underlie human hereditary diseases. The combination of TessArae’s expertise in microarray-based resequencing with novel nucleotide sequence basecalling algorithms and analysis software enables screening for [...]
Posted in Press Releases | No Comments